The drug maker Merck says it's developed a new daily cholesterol pill that can dramatically lower LDL, or bad cholesterol. CBS News medical contributor Dr. Celine Gounder explains what to know.
Breakdown
- Merck has developed a new daily oral cholesterol pill, Enlicitide, which lowers LDL cholesterol. 7s
- A study of nearly 3,000 people showed almost 60% LDL reduction at 24 weeks when combined with statins. 1m 4s
- Enlicitide works differently from statins and showed no increased side effects compared to placebo. 1m 17s
- The study results have not yet been published or peer reviewed, and only LDL reduction—not prevention of heart attacks or strokes—was measured. 2m 3s
- Merck plans to seek FDA approval in early 2026 and hopes to launch the drug in 2027; cost is unknown. 2m 34s